Centre Léon Bérard
Centre Léon Bérard
Lyon, France9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ENCOrafenib With Binimetinib in bRAF NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2026-08-11 | NCT04526782 | |
| Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma | Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Tertiary Lymphoid Structures, neoplasm, sarcoma | Active, not recruiting | Phase 2 | 2026-07-24 | NCT04874311 | |
| A First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Anti-tumour Activity of TAX2 in Patients With Relapsed/Refractory Advanced/Metastatic Solid Tumours | Solid Tumor Cancers | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-07 | NCT07688148 | |
| Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer | Oligometastatic Disease; Solid Tumor, Adult | Recruiting | Phase 1 / Phase 2 | 2025-12-01 | NCT06439888 | |
| Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, neoplasm | Recruiting | Phase 3 | 2025-06-15 | NCT05874063 | |
| Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 / Phase 3 | 2024-12-20 | NCT05462613 | |
| Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma. | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, anus disorder, anus neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm | Active, not recruiting | Phase 2 | 2024-12-20 | NCT04719988 | |
| Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, anal squamous cell carcinoma, anus disorder, anus neoplasm, carcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, metastatic squamous cell carcinoma, neoplasm, rectal disorder, rectal neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2023-12-22 | NCT04894370 | |
| GastrOesophageal Tumor, Immune Microenvionnment (GOTIM) | gastroesophageal cancer | Recruiting | Not stated | 2023-08-30 | NCT05644431 |